Position in TBPH
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$12,401,423
+$1,728,772 QoQ
Shares Held
764,105
+34.0% QoQ
Ownership
1.48%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in TBPH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $7,583,514,316 across 563 Biotechnology names. TBPH ranks #85 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 | |
| 8 | MRNA |
Moderna, Inc.
|
4,407,907 | $223,921,674 |
All Filings in TBPH
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,401,423 | 764,105 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $10,672,651 | 570,425 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $7,506,880 | 514,170 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $4,380,376 | 397,133 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,729,354 | 417,621 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,639,644 | 174,245 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $247,901 | 30,757 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $286,386 | 33,772 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $530,027 | 59,089 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $798,107 | 71,006 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $463,586 | 53,718 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $442,058 | 42,711 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $289,955 | 26,724 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $97,120 | 8,656 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $1,014 | 100 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $2,654 | 293 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $33,928 | 3,549 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $27,049 | 2,448 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $5,661 | 765 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,452 | 100 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $4,470,565 | 219,038 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $2,988,896 | 168,199 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $1,223,813 | 82,774 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $52,999 | 2,525 | Shares | Defined | 2020-07-31 | |
| 2020-03-31 | $103,486 | 4,478 | Shares | Defined | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||